AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Return on Assets

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22B
P/E ratio
-390.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Dec 31, 20254.9-182.47%
Dec 31, 2024-6+21.50%
Dec 31, 2023-4.9-139.16%
Dec 31, 202212.6-21.02%
Dec 31, 202115.9-219.31%
Dec 31, 2020-13.4-11233.33%
Dec 31, 20190.1-100.50%
Dec 31, 2018-24.2+1792.97%
Dec 31, 2017-1.3-92.29%
Dec 31, 2016-16.6-55.45%
Dec 31, 2015-37.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)